A candid case study of a failed pharma startup deal — lessons on risk, relationships, and protecting a startup’s business.
Learn about the challenges of rare disease drug development and care and how digital health has the potential to revolutionize nearly every aspect.
Naomi Fried, PhD, sits down with host Ellie Hanson and shares valuable insights into how startups can navigate pharma partnerships.
A gap exists between pharma and digital health startup that prevents them from engaging in fruitful partnerships. What's going wrong?
To advance digital health, pharmaceutical companies and start-ups should partner. There are many benefits to both from working together.
Digital health is new and exciting, but also fraught with complexity. We need a framework to understand how to navigate our way through the world of Digital Healthcare.
What will 2020 and beyond bring for the digital health ecosystem?